Stocktoria
PAVmed Inc. PAVM
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-07-27
PAVmed Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $71,000 | $3.0M | $2.5M | $377,000 | $500,000 |
| Gross profit | — | — | — | — | -$85,000 |
| R&D expense | $4.5M | $5.9M | $14.3M | $25.3M | $19.8M |
| Operating income | -$21.8M | -$44.5M | -$68.8M | -$91.1M | -$54.4M |
| Income tax | $0 | $0 | — | — | — |
| Net income | $401,000 | $39.8M | -$64.2M | -$89.0M | -$50.3M |
| EPS (diluted) | $-5.63 | $14.90 | $-9.16 | $-15.03 | — |
| Operating cash flow | -$5.2M | -$33.6M | -$52.0M | -$71.0M | -$40.6M |
| Free cash flow | -$5.2M | -$33.6M | -$52.3M | -$72.5M | -$42.1M |
| Cash & equivalents | $1.5M | $1.2M | $19.6M | $39.7M | $77.3M |
| Inventory | — | — | $278,000 | $111,000 | — |
| Total assets | $38.8M | $30.7M | $33.1M | $54.0M | $87.0M |
| Total liabilities | $16.5M | $37.7M | $57.1M | $43.0M | $7.6M |
| Shareholders' equity | $34.0M | -$7.0M | -$53.8M | $10.9M | $79.4M |
Source: SEC EDGAR filings · CIK 0001624326 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.